Peramivir
Links shared publicly online about this topic
FDA Alert: Peramivir IV
drugs.com — “FDA Alert: Peramivir IV” View full resource at drugs.com
Most Recently Shared on October 30, 2009 at 1:34 am By:
RT @drugscom FDA Alert: Peramivir IV http://bit.ly/2Mar8x
FDA Alert: Peramivir IV
drugs.com — “FDA Alert: Peramivir IV” View full resource at drugs.com
Most Recently Shared on October 28, 2009 at 9:45 pm By:
FDA Alert - FDA Authorizes Emergency Use of Intravenous Antiviral Peramivir - http://bit.ly/1jhHlM
ingentaconnect Peramivir: Lack of efficacy and development of resistance in infl...
ingentaconnect.com — “ingentaconnect Peramivir: Lack of efficacy and development of resistance in infl...” View full resource at ingentaconnect.com
Most Recently Shared on June 19, 2011 at 3:55 am By:
Peramivir: Lack of efficacy and development of resistance in influenza A virus H1N1 subtype: case report: (Sourc... http://bit.ly/lJjuC2
Phase 3 study of peramivir for the treatment of influenza - ONA
oncologynurseadvisor.com — “BioCryst Pharmaceuticals announced top-line results from one of its two Phase 3 studies of intravenous (i.v.) peramivir for the treatment of patients hospitalized with influenza.” View full resource at oncologynurseadvisor.com
Most Recently Shared on January 14, 2011 at 4:32 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Phase 3 study of peramivir for the treatment of influenza http://goo.gl/fb/B4ymp
Phase 3 study of peramivir for the treatment of influenza - MPR
empr.com — “BioCryst Pharmaceuticals announced top-line results from one of its two Phase 3 studies of intravenous (i.v.) peramivir for the treatment of patients hospitalized with influenza.” View full resource at empr.com
Most Recently Shared on January 14, 2011 at 7:06 pm By:
MPR News: Phase 3 study of peramivir for the treatment of influenza: BioCryst Pharmaceuticals announced top-line... http://bit.ly/fo5tiF
Green Cross seeks regulatory approval for peramivir in S.Korea
news-medical.net — “BioCryst Pharmaceuticals, Inc. today announced that it has been informed by its partner, Green Cross Corp., that Green Cross has filed a New Drug Application (NDA) in South Korea to seek regulatory approval for intravenous (i.v.) peramivir to treat patients with influenza.” View full resource at news-medical.net
Most Recently Shared on January 9, 2010 at 5:56 am By:
Green Cross seeks regulatory approval for peramivir in S.Korea: BioCryst Pharmaceuticals, Inc. today announced tha... http://bit.ly/8vukCC
FDA Authorizes Emergency Use Of Intravenous Antiviral Peramivir For 2009 H1N1 Influenza For Certain Patients, Settings
medicalnewstoday.com — “The U.S. Food and Drug Administration announced that, in response to a request from the U.S. Centers for Disease Control and Prevention, it has issued an emergency use authorization (EUA) for the” View full resource at medicalnewstoday.com
Most Recently Shared on October 26, 2009 at 3:55 pm By:
MNT Swine Flu News Health News
FDA Authorizes Emergency Use Of Intravenous Antiviral Peramivir For 2009 H1N1 Influenza For Certain .. http://bit.ly/4xjBgc #swine_flu
Hospital Medicine Quick Hits » Blog Archive » Peramivir effective for influenza
blogs.hospitalmedicine.org — “Hospital Medicine Quick Hits » Blog Archive » Peramivir effective for influenza” View full resource at blogs.hospitalmedicine.org
Most Recently Shared on December 7, 2010 at 11:13 pm By:
Wiley Health Medical Health Site
Peramivir effective for influenza: Peramivir was FDA approved last influenza season for emergency use with sever... http://bit.ly/embKF1
NEJM -- The Emergency Use Authorization of Peramivir for Treatment of 2009 H1N1 Influenza
content.nejm.org — “Perspective from the new england journal of medicine -- the emergency use authorization of peramivir for treatment of 2009 h1n1 influenza” View full resource at content.nejm.org
Most Recently Shared on November 3, 2009 at 12:51 pm By:
NEJM -- Peramivir in treatment of H1N1 http://bit.ly/1g68dZ
Symposier - Emergency Use of Peramivir to Treat H1N1 (January 2010)
symposier.com — “Uploaded and Shared in Youtube by: LawsuitGuru FDA has authorized the emergency use of the investigational antiviral drug peramivir for certain adults and children hospitalized with confirmed or suspected 2009 H1N1 influenza. This includes patients who have an influenza A virus that is non-subtypeable and is suspected to be 2009 H1N1 based on cases in the community. Peramivir, which is administered intravenously, is in the same drug class as Tamiflu and Relenza. Peramivir is authorized only unde” View full resource at symposier.com
Most Recently Shared on March 2, 2010 at 5:45 pm By:
FDA has authorized the emergency use of Emergency Use of Peramivir to Treat H1N1. http://bit.ly/cOHxqg
FDA approves emergency use of intravenous peramivir against swine flu | Booster Shots | Los Angeles Times
latimesblogs.latimes.com — “Responding to a request from the Centers for Disease Control and Prevention, the Food and Drug Administration on Friday approved emergency use of the experimental intravenous antiviral drug peramivir to treat hospitalized patients with pandemic H1N1 influenza. Tamiflu, the primary...” View full resource at latimesblogs.latimes.com
Most Recently Shared on October 24, 2009 at 4:40 pm By:
LA Times Health News Health News
FDA approves emergency use of intravenous peramivir against swine flu http://bit.ly/BOcjC
Emergency use authorization (EUA) issued for peramivir for H1N1 influenza infection - MPR
empr.com — “The FDA has notified healthcare professionals that it has issued an Emergency Use Authorization (EUA) for intravenous peramivir (from BioCryst Pharmaceuticals), an investigational antiviral drug, for use in certain adult and pediatric patients with confirmed or suspected 2009 H1N1 influenza infection who are admitted to a hospital.” View full resource at empr.com
Most Recently Shared on October 26, 2009 at 4:26 pm By:
MPR News: Emergency use authorization (EUA) issued for peramivir for H1N1 influenza infection: The FDA.. http://bit.ly/Uasgh
BioCryst reports positive late-stage flu data for peramivir - FierceBiotech
fiercebiotech.com — “With the world's first pandemic in more than four decades covering the globe, biocryst took another step toward fda approval for its flu therapy peramivir with the announcement that two late-stage... read more...” View full resource at fiercebiotech.com
Most Recently Shared on October 19, 2009 at 10:53 pm By:
Late stage flu-data on EUA swine flu anti-viral Peramivir, available on compassionate use basis. http://bit.ly/2FnUQz
BioCryst to present intravenous peramivir data for influenza treatment at IDSA meeting
news-medical.net — “BioCryst Pharmaceuticals, Inc. today announced the presentation of data related to intravenous (i.v.) peramivir for the treatment of influenza at the 48th Annual Infectious Diseases Society of America (IDSA) meeting being held in Vancouver, Canada.” View full resource at news-medical.net
Most Recently Shared on October 21, 2010 at 4:43 pm By:
H1N1 Swine Flu News: BioCryst to present intravenous peramivir data for influenza treatment at IDSA meeting: Bio... http://twurl.nl/c2z55l
Shionogi receives expanded approval for pediatric use of i.v. peramivir in Japan
news-medical.net — “BioCryst Pharmaceuticals, Inc. today announced that its partner, Shionogi & Co., Ltd. has received approval for an additional indication for use of intravenous (i.v.) peramivir to treat children and infants with influenza in Japan. In January 2010, Shionogi received the world's first approval for i.v. peramivir and launched it under the commercial name RAPIACTA® in Japan.” View full resource at news-medical.net
Most Recently Shared on October 27, 2010 at 5:05 pm By:
H1N1 Swine Flu News: Shionogi receives expanded approval for pediatric use of i.v. peramivir in Japan: BioCryst ... http://twurl.nl/37w17y
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Patricia Goode
Christian Healthcare, Legal and Marketing Consultant
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
OrganizedWisdom Flu
Organizing influenza and cold resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
